Viewing nowCombinationDuoWell Plus Tablet 80/10/10 Milligrams
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation

MFDS item code 202106631 · Approved 2021.09.24 · Insurance code 642105810
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
This medication is used for patients who need to take telmisartan and rosuvastatin/ezetimibe simultaneously. First, telmisartan helps reduce the risk of myocardial infarction, stroke, and death from cardiovascular diseases in patients with essential hypertension and those in high-risk groups for cardiovascular diseases. Additionally, it is used as an alternative treatment for patients who cannot take ACE inhibitors. Meanwhile, rosuvastatin/ezetimibe supports cardiovascular health by improving blood cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia. This medication reduces total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol while increasing HDL (good) cholesterol. Therefore, this medication is used to improve both blood pressure and cholesterol management, thereby lowering the risk of cardiovascular diseases.
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of telmisartan is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended starting dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg once daily. Patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication should not be used by pregnant women. If taken during pregnancy, it can cause serious harm to the fetus or newborn, so it should be discontinued immediately upon confirmation of pregnancy. There is a risk of muscle problems, so if severe muscle pain or weakness occurs, consult your doctor immediately. Special caution should be exercised in cases of severe infections, surgery, trauma, electrolyte imbalances, etc. Patients with poor liver function or a history of liver disease should consult their doctor before taking this medication and have regular liver function tests. Patients with severely impaired kidney function or certain kidney diseases should avoid using this medication, and caution is needed even in cases of mild kidney impairment. Interactions may occur when taken with other drugs, so if you are currently taking any medications, be sure to inform your healthcare provider, especially when taken with certain antibiotics, antifungals, immunosuppressants, antihypertensive drugs, etc. This medication may increase potassium levels in the blood, so patients with hyperkalemia or at high risk should frequently check their blood potassium levels. Side effects such as muscle pain, fatigue, headache, indigestion, dizziness, etc. may occur, and if symptoms are severe or persist, consult your doctor. Dizziness or drowsiness may occur when driving or operating machinery, so caution is advised, especially when initially taking or changing the dosage. This medication contains certain dyes, so patients with allergies to these dyes must consult their healthcare provider before taking it. During treatment, it is important to have regular blood tests and liver function tests to check for abnormalities, and if any adverse symptoms appear, inform your healthcare provider immediately.
Increased ALT, Increased AST, Increased Ɣ-GTP, Increased ALP, Abdominal pain, Oral ulcer, Vomiting, Chest pain, Palpitations, Dizziness, Shortness of breath, Functional abnormality of the Eustachian tube, Tympanic membrane perforation, Acute kidney injury, Hematuria, Herpes zoster, Pneumonia, Non-small cell lung cancer, Hair loss, Dysuria, Rhinitis, Pharyngeal discomfort, Pulmonary disease, Unspecified intestinal disease, Benign gastrointestinal neoplasm, Hemorrhoids, Skeletal pain, Osteoporosis, Sensory loss, Movement disorder, Atherosclerosis, Frequent urination, Tinnitus, Hearing loss, Halitosis, Fatty liver, Chest pain, Facial swelling, Strange sensations, Drug intolerance, Colonic polyps, Irritable bowel syndrome, Esophagitis, Somnolence, Neurodegenerative disorders, Orthostatic dizziness, Migraine, Diabetes, Glucose tolerance disorder, Depression, Bronchitis, Cystitis, Tinea unguium, Soft tissue inflammation, Hepatic steatosis, Liver impairment, Hepatotoxicity, Acute hepatitis, Toxic hepatitis, Increased gamma-glutamyl transferase, Increased blood cholesterol, Increased blood alkaline phosphatase, Irregular heart rate, Osteoarthritis, Musculoskeletal stiffness, Musculoskeletal discomfort, Muscle weakness, Diaphoresis, Dermatitis, Skin burning sensation, Skin disorders, Alopecia, Pharyngeal pain, Nasal congestion, Respiratory distress, Pelvic pain, Breast cysts, Eyelid drooping, Diabetic retinopathy, Ear discomfort, Kidney dysfunction, Benign esophageal neoplasm, Upper respiratory tract infection, Urinary tract infection, Sepsis, Anemia, Thrombocytopenia, Eosinophilia, Hypersensitivity, Anaphylactic reaction, Hyperkalemia, Hypoglycemia, Depression, Insomnia, Anxiety, Syncope, Visual disturbances, Dizziness, Bradycardia, Tachycardia, Hypotension, Orthostatic hypotension, Abdominal pain, Diarrhea, Dyspepsia, Abdominal bloating, Abdominal discomfort, Dry mouth, Abnormal liver function, Liver disease, Increased sweating, Itching, Rash, Erythema, Angioedema, Drug rash, Toxic skin rash, Eczema, Hives, Myalgia, Lumbago, Muscle cramps, Arthralgia, Limb pain, Tendon pain, Acute renal failure, Asthenia, Influenza-like illness, Increased serum creatinine, Increased serum uric acid, Elevated liver enzymes, Increased serum creatine kinase, Decreased hemoglobin, Hypoglycemia, Headache, Facial spasms, Sensory abnormalities, Paralysis, Cough, Hyperventilation, Pneumonia, Flushing, Erectile dysfunction, Weakness, Edema, Decreased libido, Facial swelling, Conjunctivitis, Tinnitus, Petechiae, Polyneuropathy, Amnesia, Peripheral neuropathy, Diarrhea, Thrombocytopenia, Jaundice, Hepatitis, Increased transaminases, Stevens-Johnson syndrome, Drug reaction syndrome with eosinophilia and systemic symptoms, Lupus-like syndrome, Muscle rupture, Immune-mediated necrotizing myopathy, Hematuria, Edema, Cognitive impairment, Headache, Dizziness, Cough, Dyspepsia, Palpitations, Arthralgia, Fatigue, Numbness, Chest discomfort, Anorexia, Abdominal bloating, Abnormal liver function tests, Syncope, Generalized pain, Muscle cramps, Gout, Erectile dysfunction, Acute renal failure, Oliguria, Thrombocytopenia, Increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is important to maintain a storage temperature between 1 degree to 30 degrees Celsius.
Yellow oval film-coated tablet
30 tablets/box [6 tablets/PTP X 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Green Cross Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
(Co., Ltd.) Green Cross
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.